Quick summary: Importation of US-Authorized Vasopressin Injection, USP, 20 units/mL (For IV Infusion) Due to the Current Shortage of Canadian-Authorized Vasopressin Injection, USP, 20 units/mL (For IM or SC Administration). Reason: Product safety - Packaging - Supply. Category: Drugs. Date: 2026-03-04.
Importation of US-Authorized Vasopressin Injection, USP, 20 units/mL (For IV Infusion) Due to the Current Shortage of Canadian-Authorized Vasopressin Injection, USP, 20 units/mL (For IM or SC Administration)
2026-03-04
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Importation of US-Authorized Vasopressin Injection, USP, 20 units/mL (For IV Infusion) Due to the Current Shortage of Canadian-Authorized Vasopressin Injection, USP, 20 units/mL (For IM or SC Administration). Reason: Product safety - Packaging - Supply. Category: Drugs. Date: 2026-03-04.
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
Affected products
Issue
What you should do
- See Key Messages below
Additional official information
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.